Maynard Um
-
-
-
-
-
-
-
Raymond James on Maze Therapeutics (MAZE): 'Sell-off on HORIZON Update Looks Like an Overreaction'
-
-
-
-
-
-
-
Truist Securities Starts Maze Therapeutics (MAZE) at Buy
-
-
-
-
-
-
-
Maze Therapeutics (MAZE) PT Raised to $60 at H.C. Wainwright
-
-
-
-
-
-
-
Maze Therapeutics (MAZE) PT Raised to $34 at Guggenheim
-
-
-
-
-
-
-
Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss of $1.15
-
-
-
-
-
-
-
Maze Therapeutics (MAZE) Files for 7.8M Share IPO at $15-$17/sh
404,884 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

